Prazolok ER 5mg Tablet contains Ilaprazole (5 mg) in an Extended-Release (ER) formulation. It is a proton pump inhibitor (PPI) that reduces gastric acid production by inhibiting the $H^+/K^+$-ATPase enzyme system in the stomach lining, providing prolonged acid suppression.
Treatment of gastroesophageal reflux disease (GERD) and erosive esophagitis
Treatment of gastric and duodenal ulcers
Long-term maintenance and healing of acid-related mucosal injury
Combination therapy for the eradication of Helicobacter pylori infections
Adults: Typically 1 tablet (5 mg) taken once daily in the morning, swallowed whole at least 30 minutes before breakfast. Do not crush or chew the extended-release tablet.
Children: Safety and efficacy have not been established for pediatric patients.
Use as prescribed by a physician.
Nausea, diarrhea, or abdominal pain
Flatulence and headache
Dizziness or dry mouth
Mild skin rash or itching (rare)